How can we better identify patients at risk of developing cardiovascular disease? Drs Davidson, Ginsberg, and Chapman provide the lowdown on strategies to identify and treat patients with mixed dyslipidemia and ensure they achieve all their target lipid levels.
When and how do you treat elevated triglycerides? Click to take the survey and immediately compare your answers with your colleagues. Your responses will guide us in our selection of topics for future CME programming.
Join Drs Frank Sacks, Peter Jones and Theodore Mazzone as they discuss how the results of new clinical trials will affect the treatment of mixed dyslipidemia and reduce cardiovascular risk in patients with type 2 diabetes.
Join Drs Christie Ballantyne and Michael Davidson as they discuss the barriers to reaching target levels of all three key lipid components - LDL-C, HDL-C and triglycerides in the reduction of cardiovascular risk.
Acknowledgements
CME provider: Medscape.
The Mixed Dyslipidemia clinical theme is supported by an independent educational grant from Abbott Laboratories.